SOPHiA GENETICS (SOPH) Price to Sales (2021 - 2026)

SOPHiA GENETICS has disclosed Price to Sales across 6 years of filings, most recently posting 16.95 for Q2 2026.

• In Q2 2026, Price to Sales rose 50.26% year-over-year to 16.95; the TTM figure through Jun 2026 stood at 4.59 (up 54.59% YoY), while the FY2025 annual figure was 4.14, up 31.76% from the prior year.
• Price to Sales came in at 16.95 for Q2 2026 at SOPHiA GENETICS, up from 15.63 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 45.45 in Q1 2022 to a low of 9.89 in Q4 2022.
• Average Price to Sales over 5 years is 17.38, with a median of 15.97 recorded in 2025.
• Year-over-year, Price to Sales slumped 87.99% in 2022 and surged 82.29% in 2023.
• Over 5 years, Price to Sales stood at 9.89 in 2022, then surged by 82.29% to 18.02 in 2023, then tumbled by 35.94% to 11.55 in 2024, then climbed by 27.62% to 14.73 in 2025, then increased by 15.06% to 16.95 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 16.95 in Q2 2026, 15.63 in Q1 2026, and 14.73 in Q4 2025.